Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution

Supportive Care in Cancer

Volumn 7, Issue 6, 1999, Pages 428-431

  Krcmery Jr , V ^a,b   Mrazova, M ^c   Kunova, A ^a   Grey, E ^c   Mardiak, J ^a   Jurga, L ^c   Sabo, A ^c   Sufliarsky, J ^a   Sevcikova, L ^a   Sorkovska, D ^a   West, D ^d   Trupl, J ^a   Novotny, J ^c   Mateicka, F ^c  

^a Natl Cancer St Elizabeth's C ^*  (Slovakia)

^b Heydukova 10   (Slovakia)

^c TRNAVA UNIVERSITY   (Slovakia)

^d UNIVERSITY OF SCRANTON   (United States)

Author keywords

Cancer patients; Fungaemia; Non albicans Candida spp.

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYTOTOXIC AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA ALBICANS; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA STELLATOIDEA; CANDIDA TROPICALIS; CANDIDIASIS; CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; HOSPITAL INFECTION; HUMAN; MORTALITY; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CATHETERIZATION; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; FLUCONAZOLE; FUNGEMIA; HUMANS; INCIDENCE; NEOPLASMS; NEUTROPENIA; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RISK FACTORS; SLOVAKIA;

EID: 0345286870     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050304     Document Type: Article

References (13)

1. Abi Said D, Annaisie E, Uzun O, Rod I, Pinczoweski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122-1128
2. Ellis M, Hussain QSM, Spence D, Halim M, Ernst P, Clink H, Baillie F, De Vol EB (1994) The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures. J Antimicrob Chemother 33:1223-1228
3. Girmenia C, Martino P, De Bernardis F, Gentile G, Boccanera M, Monaco M, Antonucci G, Cassone A (1996) Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies. Clin Infect Dis 23:506-514
4. Hong-Nguyen M, Peacock JE, Tanner DC, Morris AJ, Nguyen ML, Suydman DK, Wagener MH, Yu V (1995) Therapeutic approach in patients with candidaemia. Arch Intern Med 155:2429-2437
5. Jarvis WR (1995) Epidemiology of nosocomial fungal infections with emphasis on Candida species. Clin Infect Dis 20:1526-1530
6. Kunova A, Trupl J, Spanik S, Drgona L, Sufliarsky J, Lacka J, Studena M, Grey E, Studena V, Kukuckova E, Kollar T, Pichna P, Oravcova E, Krcmery V Jr (1995) Candida glabrata, Candida krusei, NAC and other fungal organisms in a sixty bed national cancer center in 1989-1993: no association with the use of fluconazole. Chemotherapy 41:39-44
7. Pfaller MA, Chalberg RJ, Barry AL, Rex JH for the NIAID Mycoses Study Group (1995) Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions. Clin Infect Dis 21:1507-1509
8. Stamos JK, Rowley AH (1995) Candidaemia in a paediatric population. Clin Infect Dis 20 571-575
9. Viscoli C, Girmenia C, Marinus A, Colette L, Martino P, Leban B, Spence D, Krcmery V Jr, Meunier F (1996) Candidaemia in cancer patients (abstract 40-31). Abstracts 34th Annual Meeting of the Infectious Diseases Society of America, New Orleans, 18-20 September 1996
10. Wan't Wout J (1996) Fluconazole treatment of infections caused by non-albicans Candida species. Eur J Clin Microbiol Infect Dis 15:362-366
11. Wingard JR (1995) Importance of Candida species other than C. albicans. Antimicrob Agents Chemother 22:133-139
12. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saval R (1991) Increase of Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277
13. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saval R (1993) Association of Torulopsis glabrata infections with fluconazole prophylaxis in bone marrow transplant patients. Antimicrob Agents Chemother 37:1847-1849